Free Trial
NYSE:ALUR

Allurion Technologies Q3 2023 Earnings Report

Allurion Technologies logo
$2.37 -0.20 (-7.62%)
Closing price 04/15/2025 03:59 PM Eastern
Extended Trading
$2.46 +0.09 (+4.02%)
As of 07:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Allurion Technologies EPS Results

Actual EPS
-$54.25
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Allurion Technologies Revenue Results

Actual Revenue
$12.96 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Allurion Technologies Announcement Details

Quarter
Q3 2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Allurion Technologies' Q1 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled on Wednesday, May 14, 2025 at 12:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Remove Ads

Allurion Technologies Earnings Headlines

What to do with your collapsing portfolio…
There might be only one way to save your retirement in this volatile time. After watching investors lose $6 trillion in market cap in a matter of DAYS... And after seeing businesses bleeding dry as trade tensions spiral out of control... What the acclaimed “Market Wizard” Larry Benedict — who beat the market by 103% during the 2008 crash — is about to reveal could not only save your retirement from Trump's tariffs…
Allurion Technologies reports Q4 EPS ($7.95), consensus ($5.70)
See More Allurion Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Allurion Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Allurion Technologies and other key companies, straight to your email.

About Allurion Technologies

Allurion Technologies (NYSE:ALUR) focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

View Allurion Technologies Profile

More Earnings Resources from MarketBeat